Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Which outcomes should be measured in hand eczema trials? Results from patient interviews and an expert survey.

< BACK TO ARCHIVE


2023 Jan 25


J Eur Acad Dermatol Venereol


http://www.ncbi.nlm.nih.gov/pubmed/36695080?dopt=Abstract

Which outcomes should be measured in hand eczema trials? Results from patient interviews and an expert survey.

Authors

Which outcomes should be measured in hand eczema trials? Results from patient interviews and an expert survey.
Rönsch H, Schiffers F, Ofenloch R, Weisshaar E, Buse AS, Hansen A, John SM, Giménez Arnau AM, Pesqué D, Agner T, Nørreslet LB, Loman L, Romeijn GLE, Schuttelaar MLA, Košćec Bjelajac A, Macan J, Bauer A, Apfelbacher C
J Eur Acad Dermatol Venereol. 2023 Jan 25.
PMID: 36695080.

Abstract

Hand eczema (HE) is a common skin disease characterised by itch, pain, and visible skin changes such as fissures, erythema, and vesicles. It is not yet clear which outcome domains are most important for patients. The Hand Eczema Core Outcome Set (HECOS) initiative is developing a consented set of core domains and suitable measurement instruments for the future application in all HE trials. This includes an online Delphi survey about core domains, which requires a 'Long List' of all domains that might be important to measure.
Read This Paper